🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to evaluate the safety, tolerability and efficacy of molnup...
Status
Terminated
Location
Kaiser Foundation Hospital - South Bay ( Site 1832)
Start Date
2020-10-19
Trial ID
NCT04575584
Treatments Being Tested
This retrospective real-world target trial emulation uses complete Czech na...
Status
Completed
Location
Department of Pharmacology, Third Faculty of Medicine, Charles University
Start Date
2022-01-01
Trial ID
NCT07720596
Treatments Being Tested
The AGILE platform master protocol allows incorporation of a range of ident...
Status
Recruiting
Location
Desmond Tutu Health Foundation
Start Date
2020-07-03
Trial ID
NCT04746183
This trial will use a previously validated platform, to quantitatively asse...
Status
Recruiting
Location
Universidade Federal de Minas Gerais
Start Date
2023-02-22
Trial ID
NCT05648448
The purpose of the study is to assess if the study medication (molnupiravir...
Status
Completed
Location
Cahaba Research, Inc. ( Site 2523)
Start Date
2021-08-11
Trial ID
NCT04939428
Treatments Being Tested
The trial will develop and validate a platform for quantitative assessment ...
Status
Recruiting
Location
Universidade Federal de Minas Gerais
Start Date
2021-09-30
Trial ID
NCT05041907
Treatments Being Tested
* Research Question: Does convalescent plasma (CCP) collected from donors w...
Status
Terminated
Location
CHU Besançon
Start Date
2022-04-01
Trial ID
NCT05271929
Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Mod...
Status
Unknown
Location
Istanbul University, Istanbul Faculty of Medicine, Department of Infectious Disease
Start Date
2022-07-07
Trial ID
NCT06223932
Treatments Being Tested
The goal of the study is to learn what happens to MK-4482 after single and ...
Status
Completed
Location
Peking University Third Hospital (Site 0001)
Start Date
2023-06-28
Trial ID
NCT06816030
Treatments Being Tested
The objective of the COVID-19 International Drug Pregnancy Registry (COVID-...
Status
Recruiting
Location
Pregistry
Start Date
2021-12-01
Trial ID
NCT05013632
Treatments Being Tested